One Year Follow-up of Study 2-79-52030-207 (PRIMARYS) in Acromegalic Patients With Macroadenoma
NCT01471405
·
clinicaltrials.gov ↗
COMPLETED
Status
54
Enrollment
INDUSTRY
Sponsor class
Conditions
Acromegaly
Sponsor
Ipsen